Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Brian Lewis MD, MPH, FACP

Brian E. Lewis MD, MPH, FACP

Assistant Professor of Clinical Medicine, Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, Louisiana

Biographical Sketch:

Dr. Brian Lewis is an Assistant Professor of Clinical Medicine in the Department of Hematology and Medical Oncology at Tulane University School of Medicine in New Orleans. He is also the Chair of the Fellowship Advancement Committee of the Hematology and Medical Oncology Fellowship Program at Tulane.

Following his graduation from George Mason University in Fairfax, Virginia, Dr. Lewis enrolled in the Tulane University School of Public Health and, upon completing his MPH degree, entered medical school at Tulane. He completed his medical degree and residency training in internal medicine at Tulane, where he also completed his fellowship in hematology and medical oncology.

Dr. Lewis is a member of several professional societies, including the American Society of Hematology and the American Society of Clinical Oncology. Dr. Lewis is a Fellow of the American College of Physicians.

Positions:
Assistant Professor of Clinical Medicine, Department of Hematology and Medical Oncology; Chair, Fellowship Advancement Committee, Hematology and Medical Oncology Fellowship Program, Tulane University School of Medicine

Degrees:
MPH: Tulane University School of Public Health, New Orleans, Louisiana
MD: Tulane University School of Medicine

Disclosures

Dr. Brian Lewis does not have any financial interests to disclose.

Recent Contributions to PracticeUpdate:

  1. Radiotherapy to the Primary Tumor for Newly Diagnosed Metastatic Prostate Cancer
  2. ESMO 2018: Recommendations From Dr. Brian Lewis
  3. The Androgen Receptor Inhibitor Enzalutamide Is Approved for Castration-Resistant, Nonmetastatic Prostate Cancer
  4. ASCO 2018: Abstract Recommendations From Dr. Brian Lewis
  5. Increased Radical Prostatectomy in Men With High-Risk Localized Prostate Cancer
  6. Bipolar Androgen Therapy in Men With Metastatic Castration-Resistant Prostate Cancer After Progression on Enzalutamide
  7. Metastasis-Directed Therapy Improves PFS in Oligometastatic Prostate Cancer Recurrence
  8. 7-Month PSA Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With ADT With or Without Docetaxel
  9. Weekly Cabazitaxel Plus Prednisone Is Effective and Less Toxic for "Unfit" mCRPC
  10. 2017 Top Stories in Advanced Prostate Cancer: Abiraterone for Metastatic Castrate-Sensitive Disease

Most Read This Week

Recently Updated